N

New Horizon Research Group | Medical Affiliated Research Center

Research site

(Unclaimed)

Location

303 Williams Avenue South West Suite 511, Huntsville, Alabama, United States of America

Site insights

Top conditions

Top treatments

Testosterone

Estradiol

Vonoprazan

Lansoprazole

PRC-4016

ARD-0403

Desmopressin

DA-8159

Dapagliflozin

Cetrorelix Pamoate

Parent organization

This site is a part of New Horizon Research Group

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 73 total trials

A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis (ASCEND)

This is a randomized, double-blind, placebo-controlled, parallel-dosing, multi-center study to evaluate the efficacy and safety of Rencofilstat as ev...

Active, not recruiting

Fibrosis, Liver

Nonalcoholic Steatohepatitis (NASH)

Drug: Rencofilstat

Drug: Placebo

A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adults (PISSARRO)

This purpose of this phase 3 multicenter, parallel-group, open-label study is to learn about the safety, tolerability, and immunogenicity of RSVpreF...

Active, not recruiting

Respiratory Syncytial Virus (RSV)

Biological: RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE

Biological: HZ/su VACCINE

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults. (RENOIR)

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Enrolling

Lower Respiratory Tract Illness

Biological: RSVpreF

Biological: Placebo